Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kishore Perumandla, Rohini Devi Shesham & Krishna R. Devarakonda. (2005) Population Pharmacokinetics of Carbamazepine in Indian Epileptic Patients. Clinical Research and Regulatory Affairs 22:3-4, pages 139-157.
Read now
Read now
W. H. Murphy, W. W. Chin, J. F. Selwa, S. A. Fulton & J. F. Nawrocki. (1985) A Computer-Based Method to Rapidly Analyze Tumor Cell Lysis In. Vivo. Clinical Research Practices and Drug Regulatory Affairs 3:1, pages 83-106.
Read now
Read now
Stuart L. Beal. (1984) 1. Population Pharmacokinetic Data and Parameter Estimation Based on Their First Two Statistical Moments. Drug Metabolism Reviews 15:1-2, pages 173-193.
Read now
Read now
Articles from other publishers (20)
Monia Guidi, Chantal Csajka & Thierry Buclin. (2020) Parametric Approaches in Population Pharmacokinetics. The Journal of Clinical Pharmacology 62:2, pages 125-141.
Crossref
Crossref
A.N. Kristoffersson, V. Rognås, M.J.E. Brill, Y. Dishon-Benattar, E. Durante-Mangoni, V. Daitch, A. Skiada, J. Lellouche, A. Nutman, A. Kotsaki, R. Andini, N. Eliakim-Raz, R. Bitterman, A. Antoniadou, M.O. Karlsson, U. Theuretzbacher, L. Leibovici, G.L. Daikos, J.W. Mouton, Y. Carmeli, M. Paul & L.E. Friberg. (2020) Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria. Clinical Microbiology and Infection 26:12, pages 1644-1650.
Crossref
Crossref
Jurjen Duintjer Tebbens, Malek Azar, Elfriede Friedmann, Martin Lanzendörfer & Petr Pávek. (2018) Mathematical Models in the Description of Pregnane X Receptor (PXR)-Regulated Cytochrome P450 Enzyme Induction. International Journal of Molecular Sciences 19:6, pages 1785.
Crossref
Crossref
James S. McCarthy, Thomas R?ckle, Elhadj Djeriou, Cathy Cantalloube, Daniel Ter-Minassian, Mark Baker, Peter O?Rourke, Paul Griffin, Louise Marquart, Rob Hooft van Huijsduijnen & J?rg J. M?hrle. (2016) A Phase II pilot trial to evaluate safety and efficacy of ferroquine against early Plasmodium falciparum in an induced blood-stage malaria infection study. Malaria Journal 15:1.
Crossref
Crossref
Soham Chakraborty & Pathik Kumar Mandal. (2015) SPC based on growth models for monitoring the process of hydrogenation of edible oil. Journal of Food Engineering 146, pages 192-203.
Crossref
Crossref
Fumiyoshi Yamashita, Yukako Sasa, Shuya Yoshida, Akihiro Hisaka, Yoshiyuki Asai, Hiroaki Kitano, Mitsuru Hashida & Hiroshi Suzuki. (2013) Modeling of Rifampicin-Induced CYP3A4 Activation Dynamics for the Prediction of Clinical Drug-Drug Interactions from In Vitro Data. PLoS ONE 8:9, pages e70330.
Crossref
Crossref
P. Timothy Pollak. (2013) Nondaily Statin Dosing: Mechanisms of a Potentially Important Approach to Dealing With Statin Intolerance. Canadian Journal of Cardiology 29:8, pages 895-898.
Crossref
Crossref
Elodie L. Plan, Alan Maloney, Iñaki F. Trocóniz & Mats O. Karlsson. (2009) Performance in population models for count data, part I: maximum likelihood approximations. Journal of Pharmacokinetics and Pharmacodynamics 36:4, pages 353-366.
Crossref
Crossref
Kristin L. Bigos, Robert R. Bies & Bruce G. Pollock. (2006) Population Pharmacokinetics in Geriatric Psychiatry. The American Journal of Geriatric Psychiatry 14:12, pages 993-1003.
Crossref
Crossref
Mats Karlsson & Nicholas Holford. 2002. Simulation for Designing Clinical Trials. Simulation for Designing Clinical Trials.
Michael W. Jann, Wen-Ho Chang & Hsien-Yuan Lane. (2001) Differences in Haloperidol Epidemiologic Pharmacokinetic Studies. Journal of Clinical Psychopharmacology 21:6, pages 628-630.
Crossref
Crossref
J.M. Tr?luyer & G. Pons. (2000) Quoi de neuf en pharmacologie p?diatrique??. Archives de P?diatrie 7:12, pages 1330-1338.
Crossref
Crossref
Jürgen Brockmöller, Julia Kirchheiner, Christian Meisel & Ivar Roots. (2000) Pharmacogenetic diagnostics of cytochrome P450 polymorphisms in clinical drug development and in drug treatment. Pharmacogenomics 1:2, pages 125-151.
Crossref
Crossref
N. H. G. HolfordH. C. KimkoJ. P. R. MonteleoneC. C. Peck. (2000) Simulation of Clinical Trials. Annual Review of Pharmacology and Toxicology 40:1, pages 209-234.
Crossref
Crossref
M.-C Etienne, E Chatelut, X Pivot, M Lavit, A Pujol, P Canal & G Milano. (1998) Co-variables influencing 5-fluorouracil clearance during continuous venous infusion. A NONMEM analysis. European Journal of Cancer 34:1, pages 92-97.
Crossref
Crossref
Sandra L. Preston & George L. Drusano. (2013) Nonparametric Expectation Maximization Population Modeling of Ganciclovir. The Journal of Clinical Pharmacology 36:4, pages 301-310.
Crossref
Crossref
John C. Somberg, Hector Gomez, Robert Piepho, Andrew Whelton, Gilbert Mayor, Harold Neu & Atul Laddu. (2013) Clinical Therapeutic Conference. The Journal of Clinical Pharmacology 32:6, pages 511-519.
Crossref
Crossref
Richard D. Scheyer & Richard H. Mattson. (1991) A method for prediction of phenytoin levels in the acute clinical setting. Computers and Biomedical Research 24:6, pages 564-575.
Crossref
Crossref
Leon Aarons. (1987) Assessment of Rate of Absorption in Bioequivalence Studies. Journal of Pharmaceutical Sciences 76:10, pages 853-855.
Crossref
Crossref
Jerold S. Harmatz & David J. Greenblatt. (1987) A simplex procedure for fitting nonlinear pharmacokinetic models. Computers in Biology and Medicine 17:3, pages 199-208.
Crossref
Crossref